{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T11:51:31Z","timestamp":1793101891850,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaut.2023.103111","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T18:43:07Z","timestamp":1694457787000},"page":"103111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis"],"prefix":"10.1016","volume":"140","author":[{"given":"Jacoba C.","family":"Graver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-3576","authenticated-orcid":false,"given":"William F.","family":"Jiemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania H.A.","family":"Altulea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"van Sleen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelis S.M.","family":"van der Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenny M.P.J.","family":"Verstappen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heeringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayel H.","family":"Abdulahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke M.H.","family":"Boots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sandovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103111_bib1","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103111_bib2","first-page":"275","article-title":"F-FDG PET\/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica","volume":"34","author":"Lavado-P\u00e9rez","year":"2015","journal-title":"Rev. Espa\u00f1ola Med. Nucl. Imagen Mol."},{"key":"10.1016\/j.jaut.2023.103111_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103111_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103111_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.621098","article-title":"Innate and adaptive immunity in giant cell arteritis","volume":"11","author":"Akiyama","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103111_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/annrheumdis-2016-209217","article-title":"Ectopic expression of CXCL13, BAFF, APRIL and LT-\u03b2 is associated with artery tertiary lymphoid organs in giant cell arteritis","volume":"76","author":"Ciccia","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib7","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1136\/annrheumdis-2017-211860","article-title":"Artery tertiary lymphoid organs in giant cell arteritis are not exclusively located in the media of temporal arteries","volume":"77","author":"Graver","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fimmu.2019.00083","article-title":"Massive B-cell infiltration and organization into artery tertiary lymphoid organs in the aorta of large vessel giant cell arteritis","volume":"10","author":"Graver","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103111_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/ard.2005.036533","article-title":"Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis","volume":"64","author":"Bhatia","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s10067-007-0684-0","article-title":"The first case of a patient with neutropenia and giant cell arteritis treated with rituximab","volume":"26","author":"Mayrbaeurl","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103111_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/annrheumdis-2011-200413","article-title":"Association of ferritin autoantibodies with giant cell arteritis\/polymyalgia rheumatica","volume":"71","author":"B Baerlecken","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/annrheumdis-2012-202963","article-title":"Contribution of antiferritin antibodies to diagnosis of giant cell arteritis","volume":"72","author":"R\u00e9gent","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib13","first-page":"829","article-title":"Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis","volume":"56","author":"Kistner","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103111_bib14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B-cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"Geest","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2023.103111_bib15","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/rheumatology\/kex169","article-title":"Correction of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica","volume":"56","author":"Carvajal Alegria","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103111_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/08916934.2012.665529","article-title":"Antibody-independent B-cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B-cell capacity","volume":"45","author":"Ireland","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2023.103111_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B-cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2023.103111_bib18","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.3390\/jcm10214958","article-title":"Functionally heterogenous macrophage subsets in the pathogenesis of giant cell arteritis: novel targets for disease monitoring and treatment","volume":"10","author":"Esen","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2023.103111_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.859502","article-title":"Pathogenic role of monocytes\/macrophages in large vessel vasculitis","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103111_bib20","doi-asserted-by":"crossref","first-page":"e1164","DOI":"10.1002\/cti2.1164","article-title":"Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis","volume":"9","author":"Jiemy","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jaut.2023.103111_bib21","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/art.41887","article-title":"A distinct macrophage subset mediating tissue destruction and neovascularization in giant cell arteritis: implication of the YKL-40 - IL-13 receptor \u03b12 axis","volume":"73","author":"Sleen van","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2023.103111_bib22","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard-2022-223480","article-title":"American College of Rheumatology\/EULAR classification criteria for giant cell arteritis","volume":"81","author":"Ponte","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib23","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3389\/fimmu.2019.01981","article-title":"Leukocyte dynamics reveal a persistent myeloid dominance in giant cell arteritis and polymyalgia rheumatica","volume":"10","author":"Sleen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103111_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2023.103111_bib25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","article-title":"Interferon-\u03b3 excess leads to pathogenic accumulation of follicular helper T-cellss and germinal centers","volume":"37","author":"Lee","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jaut.2023.103111_bib26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s43587-021-00082-y","article-title":"An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging","author":"S Sayed","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.jaut.2023.103111_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102684","article-title":"Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica","volume":"123","author":"Graver","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2023.103111_bib28","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2023.103111_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1189\/jlb.69.3.331","article-title":"Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines","volume":"69","author":"Hjelmstr\u00f6m","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2023.103111_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.04.001","article-title":"The immune potential and immunopathology of cytokine-producing B-cell subsets: a comprehensive review","volume":"55","author":"Bao","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2023.103111_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ana.26101","article-title":"Characterization of extracranial giant cell arteritis with intracranial involvement and its rapidly progressive subtype","volume":"90","author":"Beuker","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2023.103111_bib32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2021-220873","article-title":"Blocking GM-CSF receptor \u03b1 with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis","volume":"81","author":"Corbera-Bellalta","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094188","article-title":"The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages","volume":"9","author":"Fernando","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2023.103111_bib34","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/ijms19061801","article-title":"Role of human macrophage polarization in inflammation during infectious diseases","volume":"19","author":"Atri","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2023.103111_bib35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B-cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B-cells","volume":"209","author":"Barr","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2023.103111_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/annrheumdis-2016-210002","article-title":"Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis","volume":"76","author":"Miloslavsky","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/annrheumdis-2021-221865","article-title":"Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"81","author":"Cid","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103111_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001652","article-title":"Need and value of targeted immunosuppressive therapy in giant cell arteritis","volume":"8","author":"Sandovici","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2023.103111_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bcp.2019.03.027","article-title":"Treatment of polymyalgia rheumatica","volume":"165","author":"Casta\u00f1eda","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jaut.2023.103111_bib40","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1016\/S2665-9913(21)00245-9","article-title":"Efficacy of rituximab in patients with polymyalgia rheumatica: a double-blind, randomised, placebo-controlled, proof-of-concept trial","volume":"3","author":"Marsman","year":"2021","journal-title":"Lancet Rheumatol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:32:16Z","timestamp":1760257936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"alternative-id":["S0896841123001208"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103111","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103111"}}